References
1. Rothan H.A., Byrareddy S.N. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020; 109: 102433. DOI: https://doi.org/10.1016/j.jaut.2020.102433
2. Boldyreva M.N. SARS-COV-2 virus and other epidemic coronaviruses: pathogenetic and genetic factors in the development of infections. Immunologyа. 2020; 41 (3): 197–205. DOI: https://doi.org/10.33029/0206-4952-2020-41-3-197-205 (in Russian)
3. World Health Organization. Coronavirus (COVID-19) Dashboard. URL: https://data.who.int/dashboards/covid19/
4. Sanchez-Mazas A., Lemaître J.F., Currat M. Distinct evolutionary strategies of human leucocyte antigen loci in pathogen-rich environments. Philos Trans R Soc Lond B Biol Sci. 2012; 367 (1590): 830–9. DOI: https://doi.org/10.1098/rstb.2011.0312
5. Khaitov R.M., Skvortsova V.I., Khaitov M.R. Biomedical safety: immunogenetics and coronavirus infection. 2022; Moscow: GEOTAR-Media, 352 p. ISBN: 978-5-9704-7382-5. (in Russian)
6. de Groot N.G., Heijmans C.M., de Groot N., Otting N., de Vos-Rouweller A.J., Remarque E.J., Bonhomme M., Doxiadis G.G., Crouau-Roy B., Bontrop R.E. Pinpointing a selective sweep to the chimpanzee MHC class I region by comparative genomics. Mol Ecol. 2008; 17 (8): 2074–88. DOI: https://doi.org/10.1111/j.1365-294X.2008.03716.x
7. Goeury T., Creary L.E., Brunet L., Galan M., Pasquier M., Kervaire B., Langaney A., Tiercy J.M., Fernández-Viña M.A., Nunes J.M., Sanchez-Mazas A. Deciphering the fine nucleotide diversity of full HLA class I and class II genes in a well-documented population from sub-Saharan Africa. HLA. 2018; 91 (1): 36–51. DOI: https://doi.org/10.1111/tan.13180
8. Garamszegi L.Z. Global distribution of malaria-resistant MHC-HLA alleles: the number and frequencies of alleles and malaria risk. Malar J. 2014; 13: 349. DOI: https://doi.org/10.1186/1475-2875-13-349
9. Shiina T., Hosomichi K., Inoko H., Kulski J.K. The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet. 2009; 54 (1): 15–39. DOI: https://doi.org/10.1038/jhg.2008.5
10. Kachuri L., Francis S.S., Morrison M.L., Wendt G.A., Bossé Y., Cavazos T.B., Rashkin S.R., Ziv E., Witte J.S. The landscape of host genetic factors involved in immune response to common viral infections. Genome Med. 2020; 12 (1): 93. DOI: https://doi.org/10.1186/s13073-020-00790-x
11. Harishankar M., Selvaraj P., Bethunaickan R. Influence of Genetic Polymorphism Towards Pulmonary Tuberculosis Susceptibility. Front Med (Lausanne). 2018; 5: 213. DOI: https://doi.org/10.3389/fmed.2018.00213
12. Lima-Junior Jda C., Pratt-Riccio L.R. Major Histocompatibility Complex and Malaria: Focus on Plasmodium vivax Infection. Front Immunol. 2016; 7: 13. DOI: https://doi.org/10.3389/fimmu.2016.00013
13. Nishida N., Ohashi J., Khor S.S., Sugiyama M., et al. Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis. Sci Rep. 2016; 6: 24767. DOI: https://doi.org/10.1038/srep24767
14. Weiskopf D., Angelo M.A., Grifoni A., O’Rourke P.H., et al. HLA-DRB1 Alleles Are Associated With Different Magnitudes of Dengue Virus-Specific CD4+ T-Cell Responses. J Infect Dis. 2016; 214 (7): 1117–24. DOI: https://doi.org/10.1093/infdis/jiw309
15. Luckey D., Weaver E.A., Osborne D.G., Billadeau D.D., Taneja V. Immunity to Influenza is dependent on MHC II polymorphism: study with 2 HLA transgenic strains. Sci Rep. 2019; 9 (1): 19061. DOI: https://doi.org/10.1038/s41598-019-55503-1
16. Falfán-Valencia R., Narayanankutty A., Reséndiz-Hernández J.M., Pérez-Rubio G., et al. An Increased Frequency in HLA Class I Alleles and Haplotypes Suggests Genetic Susceptibility to Influenza A (H1N1) 2009 Pandemic: A Case-Control Study. J Immunol Res. 2018; 2018: 3174868. DOI: https://doi.org/10.1155/2018/3174868
17. Hajeer A.H., Balkhy H., Johani S., Yousef M.Z., Arabi Y. Association of human leukocyte antigen class II alleles with severe Middle East respiratory syndrome-coronavirus infection. Ann Thorac Med. 2016; 11 (3): 211–3. DOI: https://doi.org/10.4103/1817-1737.185756
18. Shkurnikov M., Nersisyan S., Jankevic T., Galatenko A., et al. Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19. Front Immunol. 2021; 12: 641900. DOI: https://doi.org/10.3389/fimmu.2021.641900
19. Yankevich T.E., Trofimov Yu.D., Boldyreva M.N., Shubina E.S., Goltsov A.Yu., Altukhova O.S., Suslova T.A. Development of the «HLA-EXPERT» system for typing HLA genes with high resolution using the NGS method. Experience of use. Bulletin of Hematology. 2018; 14 (2): 56. eLIBRARY ID:42772096 EDN:LQXGTQ (in Russian)
20. Basir H.R.G., Majzoobi M.M., Ebrahimi S., Noroozbeygi M., et al. Susceptibility and Severity of COVID-19 Are Both Associated With Lower Overall Viral–Peptide Binding Repertoire of HLA Class I Molecules, Especially in Younger People. Front Immunol. 2022; 13: 891816. DOI: https://doi.org/10.3389/fimmu.2022.891816
21. Dobrijević Z., Gligorijević N., Šunderić M., Penezić A., et al. The association of human leucocyte antigen (HLA) alleles with COVID-19 severity: A systematic review and meta-analysis. Rev Med Virol. 2022; e2378. DOI: https://doi.org/10.1002/rmv.2378
22. Astbury S., Reynolds C.J., Butler D.K., Muсoz-Sandoval D.C., et al. HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19. Immunology. 2022; 166: 68–77. DOI: https://doi.org/10.1111/imm.13450
23. Karami Fath M., Jahangiri A., Ganji M., Sefid F., et al. SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage. Front Immunol. 2021; 12: 705772. DOI: https://doi.org/10.3389/fimmu.2021.705772
24. Dold L., Ahlenstiel G., Althausen E., Luda C., Schwarze-Zander C., Boesecke C., et al. Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART). PLoS ONE. 2015; 10 (8): e0134158. DOI: https://doi.org/10.1371/journal.pone.0134158
25. Schindler E., Dribus M., Duffy B.F., Hock K., Farnsworth C.W., Gragert L., Liu C. HLA genetic polymorphism in patients with Coronavirus Disease 2019 in Midwestern United States. HLA. 2021; 98 (4): 370–9. DOI: https://doi.org/10.1111/tan.14387